bioMérieux has introduced the BIOFIRE® SPOTFIRE® system for rapid mycoplasma testing in pharmaceutical manufacturing. The instrument provides automated sample processing and delivers molecular results in under one hour, helping quality control teams detect mycoplasma contamination during biologics, vaccine, and cell and gene therapy production. The system includes touchscreen operation, integrated barcode scanning, and stackable modules for scalable capacity, and it is compatible with the existing BIOFIRE Mycoplasma panel used in bioprocessing environments.
The post Molecular Testing System for Rapid Mycoplasma Detection appeared first on GEN – Genetic Engineering and Biotechnology News.